Cargando…
P902: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429255/ http://dx.doi.org/10.1097/01.HS9.0000846480.53684.50 |
| _version_ | 1784779383589830656 |
|---|---|
| author | Fazio, F. Di Rocco, A. Giaimo, M. T. Za, T. Ciccone, N. Sessa, M. Gamberi, B. Tomarchio, V. De Padua, L. Bongarzoni, V. Mariani, S. Rago, A. Piciocchi, A. Merli, F. Cuneo, A. De Stefano, V. Foà, R. Martelli, M. Petrucci, M. T. |
| author_facet | Fazio, F. Di Rocco, A. Giaimo, M. T. Za, T. Ciccone, N. Sessa, M. Gamberi, B. Tomarchio, V. De Padua, L. Bongarzoni, V. Mariani, S. Rago, A. Piciocchi, A. Merli, F. Cuneo, A. De Stefano, V. Foà, R. Martelli, M. Petrucci, M. T. |
| author_sort | Fazio, F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429255 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94292552022-08-31 P902: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY Fazio, F. Di Rocco, A. Giaimo, M. T. Za, T. Ciccone, N. Sessa, M. Gamberi, B. Tomarchio, V. De Padua, L. Bongarzoni, V. Mariani, S. Rago, A. Piciocchi, A. Merli, F. Cuneo, A. De Stefano, V. Foà, R. Martelli, M. Petrucci, M. T. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429255/ http://dx.doi.org/10.1097/01.HS9.0000846480.53684.50 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Fazio, F. Di Rocco, A. Giaimo, M. T. Za, T. Ciccone, N. Sessa, M. Gamberi, B. Tomarchio, V. De Padua, L. Bongarzoni, V. Mariani, S. Rago, A. Piciocchi, A. Merli, F. Cuneo, A. De Stefano, V. Foà, R. Martelli, M. Petrucci, M. T. P902: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY |
| title | P902: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY |
| title_full | P902: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY |
| title_fullStr | P902: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY |
| title_full_unstemmed | P902: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY |
| title_short | P902: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY |
| title_sort | p902: relapsed/refractory multiple myeloma patients. a multicenter retrospective analysis of eligibility criteria for car-t cell therapy |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429255/ http://dx.doi.org/10.1097/01.HS9.0000846480.53684.50 |
| work_keys_str_mv | AT faziof p902relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT diroccoa p902relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT giaimomt p902relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT zat p902relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT cicconen p902relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT sessam p902relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT gamberib p902relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT tomarchiov p902relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT depadual p902relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT bongarzoniv p902relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT marianis p902relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT ragoa p902relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT piciocchia p902relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT merlif p902relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT cuneoa p902relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT destefanov p902relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT foar p902relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT martellim p902relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT petruccimt p902relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy |